Statin Therapy CMS347v8: Inital Population 4 ASCVD Risk Score

XMLWordPrintable

    • Type: EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Priority: Moderate
    • Component/s: None
    • None
    • Hide
      Thank you for inquiring about the eCQM. For population 4, if any ASCVD risk score is >= 20, and all other initial population criteria (and no denominator exclusions) are met, then the patient would be eligible for population 4 numerator evaluation. For example, if a patient met initial population criteria and had three scores during the measurement period: 18, 20, and 19. The patient would be evaluated to assess whether they have a statin medication (active or prescribed).
      Show
      Thank you for inquiring about the eCQM. For population 4, if any ASCVD risk score is >= 20, and all other initial population criteria (and no denominator exclusions) are met, then the patient would be eligible for population 4 numerator evaluation. For example, if a patient met initial population criteria and had three scores during the measurement period: 18, 20, and 19. The patient would be evaluated to assess whether they have a statin medication (active or prescribed).
    • CMS0347v8
    • The eligible population for the measure will change depending on if the highest risk score in the measurement period should be used or the most recent risk score is used.

      Currently in the guidance section of Statin Therapy CMS347v8, it states:

      "The 10-year ASCVD risk assessment options: The 10-year ASCVD risk score is calculated using the Pooled Cohort Equations: 1) the 2013 ACC/AHA ASCVD Risk Estimator (maps to LOINC Code 79423-0) OR 2) the ACC Risk Estimator Plus (maps to LOINC Code 99055-6). If your EHR does not have either of these risk calculators, we recommend that you use the on-line versions. The 10-year ASCVD risk score (quantitative result, i.e., result.value, "%") must be documented in a structured field. The 10-year ASCVD risk assessment must be performed during the measurement period." The ASCVD clinical guidance section does not clarify if the highest or most recent ASCVD risk score during the measurement period should be used to determine if a patient meets the initial population 4 logic.

      However, the guidance section does clarify that for initial population 2, the highest LDL-C result should be used to assess if a patient meets the population 2 logic (see, "to meet Initial Population 2: If a patient has ANY previous laboratory result of LDL-C >= 190 mg/dL, report the highest value >= 190 mg/dL."). As a result, it is unclear if the highest ASCVD risk score or the most recent ASCVD risk score in the measurement period should be used to determine a patient's eligibility for population 4. 

       

      Is the ASCVD clinical guidance that a patient's highest ASCVD risk score be used when determining a patient's eligibility for population 4, or that a patient's most recent ASCVD risk score be used when determining a patient's eligibility for population 4 ? 

       

       

       

            Assignee:
            AIR EC eCQM Team
            Reporter:
            Parker Garman
            Votes:
            0 Vote for this issue
            Watchers:
            4 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: